Details for New Drug Application (NDA): 076592
✉ Email this page to a colleague
The generic ingredient in BETAMETHASONE DIPROPIONATE is betamethasone dipropionate. There are sixty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the betamethasone dipropionate profile page.
Summary for 076592
Tradename: | BETAMETHASONE DIPROPIONATE |
Applicant: | Padagis Israel |
Ingredient: | betamethasone dipropionate |
Patents: | 0 |
Pharmacology for NDA: 076592
Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 076592
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 076592 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-376 | 45802-376-32 | 1 TUBE in 1 CARTON (45802-376-32) / 50 g in 1 TUBE |
BETAMETHASONE DIPROPIONATE | betamethasone dipropionate | CREAM, AUGMENTED;TOPICAL | 076592 | ANDA | Padagis Israel Pharmaceuticals Ltd | 45802-376 | 45802-376-35 | 1 TUBE in 1 CARTON (45802-376-35) / 15 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM, AUGMENTED;TOPICAL | Strength | EQ 0.05% BASE | ||||
Approval Date: | Dec 9, 2003 | TE: | AB | RLD: | No |
Complete Access Available with Subscription